1. Clinical Overview
A potent topical combination therapy consisting of a super-high potency corticosteroid (Clobetasol propionate) and a keratolytic agent (Salicylic Acid). It is primarily used for the treatment of severe, hyperkeratotic, and inflammatory dermatoses where scaling and thickening of the skin are prominent features. The combination provides rapid anti-inflammatory, immunosuppressive, and vasoconstrictive effects from clobetasol, while salicylic acid promotes desquamation, reduces scaling, and enhances steroid penetration.
| Onset | Duration | Bioavailability |
|---|---|---|
| Anti-inflammatory and antipruritic effects of clobetasol are typically observed within 1-3 days. Keratolytic effects of salicylic acid begin within hours of application. | The anti-inflammatory effect of clobetasol can persist for several days after discontinuation. Salicylic acid's effect is local and lasts only while the medication is applied. | Topical bioavailability is variable and depends on the vehicle, skin integrity, and site of application. Systemic absorption of clobetasol is generally low (<5%) but can be significant with prolonged use on large areas, under occlusion, or on broken skin. Salicylic acid absorption can range from 1-25% topically. |
2. Mechanism of Action
Clobetasol propionate binds to intracellular glucocorticoid receptors, forming a complex that translocates to the nucleus. This complex modulates gene transcription, leading to the synthesis of anti-inflammatory proteins (lipocortins) and inhibition of pro-inflammatory mediators (cytokines, leukotrienes, prostaglandins). It also causes vasoconstriction. Salicylic Acid acts as a keratolytic by disrupting intercellular cohesion in the stratum corneum, leading to desquamation of scaly skin. It also possesses mild anti-inflammatory and bacteriostatic properties.
3. Indications & Uses
- Severe Psoriasis (especially plaque psoriasis with thick scaling)
- Chronic Lichen Planus (hypertrophic type)
- Severe Eczema/Dermatitis (with significant hyperkeratosis)
- Discoid Lupus Erythematosus (cutaneous lesions)
4. Dosage & Administration
Adult Dosage: Apply a thin film to the affected area once or twice daily. For most conditions, once-daily application is sufficient. Treatment should be limited to 2 consecutive weeks. The maximum weekly dose should not exceed 50 grams (for clobetasol).
Administration: Wash and dry the affected area. Apply a thin layer and rub in gently until absorbed. Wash hands after application unless hands are being treated. Do not cover with occlusive dressings unless specifically directed by a physician. Avoid contact with eyes, mouth, nose, and mucous membranes. Do not use on broken or infected skin.
5. Side Effects
Common side effects may include:
- Local burning or stinging sensation
- Skin dryness or irritation
- Itching at the application site
- Skin redness (erythema)
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| Other Topical Corticosteroids | Additive risk of local and systemic side effects, including HPA axis suppression. | Major |
| Warfarin and other Anticoagulants | Salicylic acid may potentiate anticoagulant effect, increasing risk of bleeding. | Major |
| Methotrexate | Salicylic acid may decrease renal excretion of methotrexate, increasing its toxicity. | Major |
| Oral Hypoglycemics (e.g., Sulfonylureas) | Salicylic acid may enhance hypoglycemic effect. Clobetasol may cause hyperglycemia. | Moderate |
| Diuretics (e.g., Furosemide) | Salicylates may reduce the diuretic and antihypertensive effects. | Moderate |
| Systemic Corticosteroids (e.g., Prednisolone) | Increased risk of HPA axis suppression and Cushingoid features. | Major |
| Topical Retinoids or other Keratolytics | Increased risk of severe local irritation and skin barrier damage. | Moderate |
7. Patient Counselling
- DO use exactly as prescribed by your doctor.
- DO apply a thin layer only to the affected area.
- DO wash your hands before and after application (unless treating hands).
- DO report any signs of infection (increased redness, pus, pain) to your doctor.
- DON'T use on the face, underarms, or groin unless specifically instructed.
- DON'T cover the area with bandages or plastic wraps unless told to do so.
- DON'T use for longer than 2 weeks unless your doctor reassesses you.
- DON'T use on children without pediatrician/dermatologist advice.
- DON'T stop using the medicine abruptly if used for a long time; follow your doctor's instructions for tapering.
8. Toxicology & Storage
Overdose: Topical Overdose (Prolonged/Excessive Use): Severe skin atrophy, striae, telangiectasia, HPA axis suppression, Cushingoid features, hyperglycemia. Systemic Salicylate Toxicity (Salicylism): Tinnitus, hearing loss, nausea, vomiting, hyperventilation, respiratory alkalosis progressing to metabolic acidosis, confusion, fever, seizures, coma.
Storage: Store at room temperature (15-25°C). Protect from light and moisture. Do not freeze. Keep the tube tightly closed. Keep out of reach and sight of children. Do not use after the expiry date printed on the pack.